Health
The Oxford vaccine dilemma – wait for a better jab, or let more people have protection? – Telegraph.co.uk
Regulator seems ready to approve a vaccine with lower efficacy rates. Will it be right giving some people lower chances of being protected?
Drug companies Sanofi and GSK also announced a delay in their Covid-19 vaccine programme on Friday, after trials showed an ‘insufficient response’ in the over-50s.
Some researchers believe the Oxford jab may actually perform better than the 62 per cent efficacy rate suggests. Nobody in the vaccine arm became seriously ill or needed hospital treatment.
Mark Woolhouse, Professor of Infectious Disease Epidemiology at the University of Edinburgh, said: I dont think we should get too hung up on the…
-
Business19 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business18 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material